Abacavir-Lamivudine Treatment Report

Category: Prescription Drugs

Most Popular Types: Epzicom, Kivexa

true

Generic Name: Abacavir-Lamivudine

What is Abacavir-Lamivudine?

An example of Abacavir-Lamivudine

Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
122 30 Efficacy_major Efficacy_moderate Efficacy_cant_tell
3 1 Efficacy_major
2 2 Efficacy_major
2 1 Efficacy_moderate
1 0
1 0

See all 130 patients currently taking Abacavir-Lamivudine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
3
Moderate
5
Mild
7
None
20

Commonly reported side effects, conditions, and hospitalizations associated with Abacavir-Lamivudine

6
4
3
3
2
1
See all 9 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Abacavir-Lamivudine. See all 16 dosages

  daily 1 daily 6 mg daily 600 mg-300 mg monthly 200 mg daily 300 mg daily 600 mg daily 600 mg-300 mg daily 900 mg daily 2 x 600 mg-300 mg daily
  5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 7 Number of Patients: 7 91 Number of Patients: 91 6 Number of Patients: 6 5 Number of Patients: 5  

Reported Stop Reasons

Why Patients Stopped Taking Abacavir-Lamivudine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 9   Other: 38%
Side effects too severe 7   Side effects too severe: 29%
Doctor's advice 6   Doctor's advice: 25%
Personal research 2   Personal research: 8%
Did not seem to work 1   Did not seem to work: 4%
Expense 1   Expense: 4%
Course of treatment ended 1   Course of treatment ended: 4%

See all 22 patients who’ve stopped taking Abacavir-Lamivudine

Currently Taking Abacavir-Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Abacavir-Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Abacavir-Lamivudine

Always
30 86%
Usually
3 9%
Sometimes
1 3%
Never
1 3%

Burden

Difficulty being on treatment

Burden of Abacavir-Lamivudine

Very
1 3%
Somewhat
1 3%
A little
10 29%
Not at all
23 66%

Cost

Paid out of pocket

Cost of Abacavir-Lamivudine

$200+
0 0%
$100-199
0 0%
$50-99
2 11%
$25-49
7 37%
< $25
10 53%

Sort by: Helpfulness | Most Recent

7 patient evaluations for Abacavir-Lamivudine

Purpose: HIV (Human Immunodeficiency Virus) (Started May 06, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Aug 24, 2011 600 mg-300 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild UsuallyUsuallyUsuallyUsuallyUsually A littleA littleA littleA littleA little
  • Icon_thumb_off 0 helpful marks
Purpose: HIV (Human Immunodeficiency Virus) (Started Dec 01, 2005)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Feb 13, 2009 600 mg-300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Side effects:
Fatigue
  • Icon_thumb_off 0 helpful marks
Purposes: Increase effect of another treatment and HIV (Human Immunodeficiency Virus) (Started Feb 22, 2004)
Date Dosage Increase effect of another treatment Perceived effectiveness HIV (Human Immunodeficiency Virus) Perceived effectiveness Side Effects Adherence Burden
Jan 25, 2009 600 mg-300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone UsuallyUsuallyUsuallyUsuallyUsually A littleA littleA littleA littleA little
Date
Jan 25, 2009
Advice & Tips
I take this drug at night with Viracept.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks
1 2 3    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is abacavir-lamivudine?

Abacavir and lamivudine is an antiviral medication. It is in a group of human immunodeficiency virus (HIV) medicines called reverse transcriptase inhibitors. Abacavir and lamivudine helps keep the HIV virus from reproducing in the body.

Abacavir and lamivudine is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Abacavir and lamivudine is not a cure for HIV or AIDS.

Abacavir and lamivudine may also be used for other purposes not listed in this medication guide.


Precautions

You should not take abacavir and lamivudine if you have liver disease. Do not take this medicine if you have ever had an allergic reaction to abacavir. Tell your doctor if you have had an allergic reaction to any medicine that contains abacavir, such as Trizivir or Ziagen. Once you have had an allergic reaction to abacavir and lamivudine, you must never use it again.

You may need a blood test before you start taking abacavir and lamivudine for the first time, or if you are restarting the medication after stopping for reasons not related to an allergic reaction.

Some people have developed a life-threatening condition called lactic acidosis while taking this medicine. You may be more likely to develop lactic acidosis if you are overweight or have liver disease, or if you have taken certain HIV or AIDS medications for a long time. Talk with your doctor about your individual risk.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:

  • kidney disease;
  • heart disease or high blood pressure; or
  • a risk factor for heart disease such as smoking, diabetes, or high cholesterol.

FDA pregnancy category C. It is not known whether abacavir and lamivudine is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant. HIV can be passed to the baby if the mother is not properly treated during pregnancy. Take all of your HIV medicines as directed to control your infection while you are pregnant.

You should not breast-feed while you are using abacavir. Women with HIV or AIDS should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.

This medication should not be given to children under 18 years old.

Avoid taking other medications that contain abacavir or lamivudine, such as Combivir, Epivir, Trizivir, or Ziagen.

Avoid having unprotected sex or sharing needles, razors, or toothbrushes. Taking this medication will not prevent you from passing HIV to other people. Talk with your doctor about safe methods of preventing HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. Symptoms of an abacavir and lamivudine overdose are not known.

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.

Do not allow this medicine to run out completely before you get your prescription refilled. It is important that you not stop taking the medicine once you have started. If you miss several doses, you may have a dangerous or even fatal allergic reaction once you start taking abacavir again. If you stop taking abacavir and lamivudine for any reason, talk to your doctor before you start taking the medication again.

Back to top

Side Effects

Stop using this medication and call your doctor at once if you have any of these signs of an allergic reaction to abacavir:

  • Group 1 - fever;
  • Group 2 - rash;
  • Group 3 - nausea, vomiting, diarrhea, stomach pain;
  • Group 4 - general tiredness, body aches;
  • Group 5 - shortness of breath, cough, sore throat.

Once you have had an allergic reaction to abacavir, you must never use it again. If you stop taking abacavir and lamivudine for any reason, talk to your doctor before you start taking the medication again.

Other serious side effects that may not be signs of an allergic reaction include:

  • stomach pain, low fever, lost appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • lactic acidosis - muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, slow or uneven heart rate, dizziness, or feeling very weak or tired;
  • fever, chills, body aches, flu symptoms; or
  • white patches or sores inside your mouth or on your lips.

Less serious side effects include:

  • changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and trunk);
  • sleep problems or strange dreams;
  • headache, depression, anxiety; or
  • mild diarrhea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Before taking this medication, tell your doctor if you are using any of the following drugs:

  • methadone (Methadose, Dolophine);
  • ribavirin (Copegus, Rebetron, Virazole);
  • interferon (Rebetron, Roferon, Intron, Alferon, Infergen, Avonex, Rebif, Betaseron, Actimune);
  • zalcitabine (ddC, Hivid); or
  • other medications that contain abacavir or lamivudine (Combivir, Epivir, Trizivir, Ziagen).

This list is not complete and there may be other drugs that can interact with abacavir and lamivudine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Epzicom, abacavir-lamivudine, and lamivudine-abacavir

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: